Diabetes Immunotherapy

Immunotherapy for diabetes is a developing area of research aimed at modulating the immune system to treat or prevent diabetes. In Type 1 diabetes, the immune system mistakenly attacks insulin-producing beta cells in the pancreas. Immunotherapy strategies seek to reprogram or suppress this immune response to preserve beta cell function.

    Related Conference of Diabetes Immunotherapy

    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 13-14, 2024

    33rd International Diabetes and Healthcare Conference

    Paris, France
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    November 27-28, 2024

    14th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy

    Diabetes Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in